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Abstract. Although typhoid is endemic to Southeast Asia, very little is known about the disease in Laos. Typhoid
vaccination is not included in the national immunization program. Although sanitation has improved, one million people
still do not have access to basic clean water sources. We describe the epidemiology and antimicrobial susceptibility
patterns of Salmonella enterica serovar Typhi (S. Typhi) infection in Laos based on isolates accrued over 18 years at
Mahosot Hospital, Vientiane. All blood cultures collected from patients presenting with fever submitted to the Microbi-
ology Laboratory at Mahosot Hospital (February 2000–December 2018) were included. This included patients from
Vientiane and four provincial hospitals and one typhoid outbreak investigation. A total of 913 (1.5%) of 60,384 blood
cultures were positive for S. Typhi. The majority of isolates with data available (712/898, 79.3%) were susceptible to all
antibiotics tested,with 59 (6.5%)multidrug-resistant (MDR) isolates,mostly fromoneoutbreak. Of 854 isolates, 12 (1.4%)
were fluoroquinolone resistant. Patient admissions peaked between March and June at the end of the dry season.
Although there are key limitations, these data give the first detailed epidemiological evidenceof typhoid in Laos. However,
estimates will be greatly influenced by access to blood culture services and health-seeking behavior. Although typhoid
multidrug resistance and fluoroquinolone resistance are not currently major issues in Laos, continued surveillance and
improved antibiotic stewardship are necessary to forestall worsening of the situation. Cost-effectiveness analysis is
needed to inform decisions regarding typhoid vaccine introduction.
INTRODUCTION
Typhoid, caused by Salmonella enterica serovar Typhi (S.
Typhi), is transmitted through contaminated food and water
and is estimated to cause > 10 million illnesses and 128,000
deaths annually worldwide.1,2 Salmonella enterica serovar
Typhi is an important cause of community-acquired bacter-
emia in South and Southeast Asia. Thailand reported a de-
crease in cases from 8.6 cases/100,000 people in 2003 to
3/100,000 people in 2014,3 and Vietnam has reported a con-
tinued decline from an estimated incidence of 14.7/100,000
people in 2003.4 Immunization programs were started in
Thailand in the 1970s and Vietnam in the 1990s, which may
have led to these decreases in case burden.3,4 The role that
water, sanitation, and hygiene initiatives and economic
growth have also had in this decline is difficult to judge, al-
though they have probably played a major role. The WHO has
long recommended immunization for people living in endemic
areas and has recently advised the use of a new prequalified
typhoid conjugate vaccine.5
There is a high frequency of multidrug-resistant (MDR) S.
Typhi in South and Southeast Asia. Multidrug-resistant S.
Typhi is defined as resistant to first-line antibiotics ampicillin,
chloramphenicol, and trimethoprim–sulfamethoxazole (co-
trimoxazole). In Southeast Asia, MDR S. Typhi was first re-
ported in Vietnam in 1992 and the first quinolone resistance in
1993.6 An increase in the frequency of resistance to cepha-
losporins, the current main parenteral treatment of typhoid
fever, has also been observed in South and Southeast Asia.7
These changes in resistance patternsmake control ofS. Typhi
even more important. As S. Typhi is a pathogen restricted to
humans, it may be possible to eliminate it with appropriate
vaccination and sanitation interventions.
Although S. Typhi is endemic in Laos and was first de-
scribed clinically in 1909 and from blood culture in 1995
(Phetsouvanh et al.,8 Clarkson et al. submitted), there are
relatively few published data about typhoid in Laos. The first
report of the causes of bacteremia in Laos between 2000 and
2004 included246 (50.9%of clinically significant bacteremias)
S. Typhi isolates from 4,512 blood culture bottle pairs.9 A
prospective study of the use of the rapid diagnostic test (RDT)
(using OneStep Salmonella Typhi Ag Rapid Detection Kit;
Standard Diagnostics, Kyonggi-do, South Korea) in Mahosot
Hospital between September 2010 and December 2011 found
S.Typhi in30 (0.99%)of3,028bloodcultures.10Subsequently, it
was shown that gyrA mutations could be detected in RDT-
derived DNA to predict fluoroquinolone resistance inS. Typhi.11
In a parallel article, we used data from sentinel surveillance
from Mahosot Hospital over a 2-year period combined with a
healthcare utilization survey in the hospital’s main catchment
area of Vientiane to develop an estimate of enteric fever in-
cidence in the community. This study found an estimated
annual incidence of typhoid of 4.7 per 100,000 persons.12 A
clinical trial carried out in Vientiane between 2001 and 2003
showed that 3 days of ofloxacin was more efficacious than
14 days of chloramphenicol for uncomplicated inpatient ty-
phoid treatment.13 The latest Lao National Treatment Guide-
lines follow this recommendation.14
There, thus, remains very limited information on the epide-
miology and burden of S. Typhi infection in Laos. Vaccination
is recommended for “most visitors” to Laos by some travel
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medicine expert systems, for example, the U.S. CDC and the
United Kingdom National Travel Health Network and
Centre.15,16 However, immunization against typhoid is not
currently included in the Lao national program, but as this is
now being considered, we reviewed the clinical, microbio-
logical, and epidemiological data relating to isolates of S.
Typhi obtained over the past 18 years at Mahosot Hospital,
Vientiane.
METHODS
Site description. Lao PDR (Laos) is a land-linked country in
Southeast Asia, which had a reported population of 6,492,000
people in 2015.17 The climate is markedly seasonal with a wet
season from late May to October, dry cool months from No-
vember to February, and dry hot months from March to May.
Routine freely accessible blood culture diagnostic services
are only currently available at central hospitals in Vientiane, the
capital of Laos, where free blood culture for febrile patients
was started at Mahosot Hospital in 2000.
Blood samples. All blood culture S. Typhi isolates identi-
fied by the Microbiology Laboratory at Mahosot Hospital
(1757936.20N, 10236943.30E) between February 2000 and
December 2018 were included. The majority of the blood
cultures (698 specimens, 76.5%) were from patients admitted
to Mahosot Hospital and other hospitals in Vientiane. In ad-
dition, isolates obtained during fever research studies (Xam
Nua provincial hospital, Huaphan Province, from 2003 to
2006; Luang Namtha and Salavan provincial hospitals from
200818; and Xieng Kuang provincial hospital from 2015) and
an outbreak investigation (Oudomxay Provincial Hospital in
2004) are also included.
Adult blood culture bottles containing 20 mL tryptic hy-
drolysate of casein and soy peptone broth (TSB) plus 0.05%
sodiumpolyanethol sulfonatewere incubated in air at 37C for
7 days (see Phetsouvanh et al.9 for more information). The
bottleswere examineddaily for turbidity andwere subcultured
onto goat blood and chocolate agar if positive. “Blind” sub-
cultures were also performed on days 1 and 7 post-
inoculation. Bacteria were identified using standard
microbiological techniques (API 20E, bioMe´rieux, Marcy
L’Etoile, France) and were confirmed as S. Typhi by aggluti-
nation with O9, Hd, and Vi antisera (Becton Dickinson Labo-
ratories, Franklin Lakes, NJ). Comprehensive antimicrobial
susceptibility testing profiles were determined using disk dif-
fusion on Mueller–Hinton agar (Oxoid, Basingstoke, UK) fol-
lowing the U.S. Clinical and Laboratory Standards Institute
(CLSI) guidelines for the year the sample was collected and
were all subsequently reinterpreted using the current CLSI
guidelines (M100, 28th edition, January 2018). Isolates were
tested against ampicillin, chloramphenicol, trimethoprim–
sulfamethoxazole (co-trimoxazole), ceftriaxone, azithromycin,
ciprofloxacin, and nalidixic acid.Where possible, isolates with
missing antimicrobial susceptibility data, in particular cipro-
floxacin for which testing started in 2013 and azithromycin for
which interpretative criteria were only available from 2016,
were retested in January 2019 to give a more complete set
of antimicrobial susceptibility results. These isolates also
had further confirmatory identification as S. Typhi, where
possible, by Matrix assisted laser desorption/ionization time
of flight mass spectrometry (MALDI-TOF MD) (bioMe´rieux).
Laboratory records were also checked for discrepant results.
Environmental factors. Climate data for Vientiane Capital
was exported from https://en.tutiempo.net/using the mean
rainfall and temperature for each month. Information on water
sources for villageswas gathered from the 2005 and 2015 Lao
census data17,19 (www.decide.la).
Statistical analysis.Typhoid hospital inpatient incidenceof
each district and province was standardized based on the
number of reported infections diagnosed in patients reaching
hospitals per 10,000 or 100,000 people, enumerated from the
district and province population using the 2005 and 2015 Lao
census data.17,19 With uncertainty about health-seeking be-
havior and access and with no data on community incidence,
these datawill beminimal estimates of the annual incidence of
hospitalized typhoid patients and cannot reflect estimates of
actual incidence in the community. Data were analyzed using
Stata version 14 (StataCorp, College Station, TX). Mapping of
cases was performed using Quantum GIS version 2.14.2
software. Relationships with water sources were compared
using the chi-squared test.
Ethics. Ethical approval for the blood culture study was
obtained from the Oxford Tropical Research Ethics Commit-
tee and from the National Ethics Committee for Health
Research.
RESULTS
Of all blood culture sets collected during the 18 years, 1.5%
(913/60,384) were positive for S. Typhi. Fifty-six (6.1%) pa-
tients were not admitted to the hospital, all from the outbreak
in Oudomxay, but for clarity, all patients are regarded as in-
patients in this analysis. The highest yearly in-hospital in-
cidencewas2002,with 2.06 hospitalized patients per 100,000
people/year, with the most recent yearly in-hospital incidence
of 0.59 cases per 100,000 people/year reported for 2018
(Figure 1). The year with the highest number of inpatients di-
agnosed was 2002 with 110 cases, followed by 2004 with 108
cases (Supplemental Figure 1). Typhoid inpatient numbers
have decreased since 2010, but there has not been a steady
trend. The median (range) age of patients was 21 (range
180 days–80 years) years, with the highest number of patients
in the 16–20 years age-group (Figure 2, Table 1). Data from all
individual patients were included in the study, although de-
nominators vary for different parameters because of in-
complete data. There was a small predominance of males
(483/846, 57.1% with gender reported). All patients were re-
ported to have had fever and 632 (78.4%) of 806 reported
headache (Table 1). One hundred and seven (11.7%) patients
reported having taken an antibiotic in the week before ad-
mission, most frequently ampicillin (17/79, 21.5% of those
who could provide the antibiotic name). The admission di-
agnosis was recorded as typhoid in only 107/525 (20.4%)
cases, whereas 108/525 (20.6%) were clinically diagnosed as
having “rickettsial disease.” Patient outcome data were not
available formost patients (684/913 patients, 74.9%) because
of self-discharge and the lack of a formal follow-up system,
but twopatientswere known tohavedied in hospital, 224were
known to be alive and improving at discharge, and one patient
was discharged moribund. Information on ileal perforations
was not available.
The number of cases peaked between themonths ofMarch
and June (Figure 3), with the greatest number of cases re-
ported in March 2002. Focusing on Vientiane Capital where
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the most complete weather data are available, there is a clear
trend seen with increases in cases following the increase in
temperature each year, with peaks usually occurring a month
before the month of highest rainfall (Supplemental Figure 2).
Home location information was available for 737 (80.7%) of
913 patients, with the highest number coming from Vientiane
Capital (295/737, 40.0%), followed by the neighboring Vien-
tiane Province (155/737, 21.0%). However, when expressed
as inpatients per 100,000 people over the 18-year period, the
highest total incidence was in the northern province of Luang
Namtha (48 hospitalized patients per 100,000 people from
2000 to 2018), mostly occurring between 2008 and 2014 (18
years total incidence; Figure 4, yearly incidence Supplemental
Figure 3). Namtha district in Luang Namtha had the highest
number of inpatients per 10,000 people with 11.8 cases/
10,000 people from 2000 to 2018, followed by Vang Vieng and
Hin Herb districts in Vientiane Province (8.6 and 8.2 cases/
10,000 people from 2000 to 2018, respectively) (Figure 5). The
highest numberof inpatients fromVientianeCapital came from
Sangthongdistrict, with 7.5 cases/10,000people from2000 to
2018. In comparison, the highest proportions of positive blood
cultures collected were from Oudomxay and Huaphan prov-
inces. However, the data from these provinces are likely to be
skewed as they largely came from investigations of suspected
typhoid outbreaks (Supplemental Figure 4). Similarly, at a
district level, the districts with the highest percentage of
positive cultures were mainly from those in which less overall
numbers of specimens were collected (Supplemental
Figure 5).
Antibiotic susceptibility data. Full antibiotic suscepti-
bility results were available from 659 (72.2%) patient iso-
lates, 239 (26.2%) had partial results, and 15 (1.7%)
isolates had no susceptibility results because of a failure to
regrow on subculture. The majority of isolates with data
available (712/898, 79.3%) were susceptible to all anti-
biotics tested. There were 71/893 (8.0%) ampicillin-
resistant, 70/865 (8.1%) chloramphenicol-resistant, and
67/885 (7.6%) co-trimoxazole–resistant isolates; 59/848
(7.0%) isolates with ampicillin, chloramphenicol, and co-
trimoxazole results were MDR (see Table 2). Twelve (12/
854, 1.4%) isolates were resistant to quinolones and 39/
854 (4.6%) isolateswere classified as being of intermediate
susceptibility (Figure 6). The two isolates that were cipro-
floxacin resistant were also nalidixic acid resistant. How-
ever, eight of the other nalidixic acid–resistant isolates had
intermediate susceptibility to ciprofloxacin (two isolates
were not tested against ciprofloxacin). Four MDR isolates
also had intermediate susceptibility or resistance to qui-
nolones, one of which also had intermediate susceptibility
to ceftriaxone. In total, 778 isolates were re-subcultured in
FIGURE 2. Frequency of Salmonella enterica serovar Typhi (S. Typhi) infections by age-group.
FIGURE 1. In-hospital incidence of Salmonella enterica serovar Typhi blood stream infections per 100,000 people in the community per year.
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2019 for testing against additional antibiotics or for con-
firmation of susceptibility results, of which 692 grew S.
Typhi. Because of space, time, and cost constraints, not all
isolates were retested against all antibiotics. However, 43/
59 of the suspected MDR isolates grew on subculture, and
all were confirmed as MDR. Results of quinolone suscep-
tibility testing were confirmed for 25 isolates that had
originally been classified as resistant or of intermediate
susceptibility. On this basis, it was assumed that the
original susceptibility results for isolates where retesting
was not possible were correct. The majority of the MDR
isolates came from an outbreak in Oudomxay Province in
2004 (37/59, 62.7% of recorded MDR cases). There have
been no further MDR isolates reported from Oudomxay,
and only four cases of MDR were recorded in the whole
country since 2004 (Figure 7). The outbreak of MDR iso-
lates in Oudomxay was probably clonal as all isolates had
similar antibiotic susceptibility patterns. If the Oudomxay
outbreak is excluded, the frequency of S. Typhi MDRwas only
22/865 (2.5%). Of the 76 isolates recorded as resistant or in-
termediate to ceftriaxone, 73 (96%) were patients admitted
between 2000 and 2004. There have been no isolates re-
sistant or intermediate to ceftriaxone since 2009.
Environmental factors. In the three provinces with highest
typhoid inpatient incidence (Vientiane Capital, Vientiane
Province, and Luang Namtha), themain drinking water source
for villages changed from unprotected wells/bore water in
435/1,515 villages (28.7%) in 2005 to bottled water in 700/
1,277 villages (54.8%) in 2015. There were significant de-
creases in people getting water from piped water, protected
and unprotected wells, and rivers and streams (P < 0.005)
between 2005 and 2015. The only water source that did not
change markedly was water from mountain sources (P =
0.093) (www.decide.la).17,19 However, there were differences
between provinces in the main water source for villages in
2015, with Vientiane Capital and Vientiane Province pre-
dominantly using bottled water (398/481 villages, 82.7% and
250/434 villages, 57.6%, respectively), whereas in Luang
Namtha,majority of thepeople (258/362, 71.3%) sourced their
water from mountain-fed water sources.
DISCUSSION
These data from blood cultures received in a single hospital
from diverse parts of Laos provide a minimal estimate of in-
patient culture-positive typhoid incidence, with the most re-
cent annual incidence in 2018 of 0.59 cases per 100,000
people. Clearly, this estimate of annual incidence of hospi-
talized typhoid is a significant underestimate of the true in-
cidence of the disease in the community as fewhospitals have
blood culture facilities and not all typhoid patients will access
hospitals or will be admitted. The Typhoid Global Burden of
Disease (GBD) study from 2017 estimated 16,767 cases
and 202 deaths from typhoid fever in Laos in 2017 through
TABLE 1
Clinical symptoms associated with patients with Salmonella enterica serovar Typhi infection over 18 years
Variable n
Patients culture positive for S. Typhi (%) 913/60,384 (1.5)
Median age (years) (range) 21 (180 days–80 years)
Female gender (%) 363 (39.8)
Mean duration of illness (days) (95% CI) 10.1 (8.9–11.2)
Mean admission temperature (C) (95% CI) 38.7 (38.6–38.8)
Mean pulse (minutes) (95% CI) 97.3 (96.2–98.4)
Peripheral blood neutrophil (%),median (range) 67 (0.2–94)
Headache (%) 632/806 (78.4)
Rigors (%) 493/799 (61.7)
Nausea (%) 292/796 (36.7)
Vomiting (%) 223/808 (27.6)
Diarrhoea (%) 385/809 (47.6)
Myalgia (%) 358/522 (68.6)
Abdominal pain (%) 297/790 (37.6)
FIGURE 3. Total number of inpatients recorded with Salmonella enterica serovar Typhi blood stream infection per month for all years and total
number of patients per month, excluding the outbreak year of 2002.
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modeling, whereas we only identified 15 culture-confirmed
inpatients in that year.20 Theconsiderable difference is likely to
be related to multiple factors, including incomplete national
case capture in our study and the GBD estimates, in the ab-
sence of local sources of data on typhoid in Laos, being based
on extrapolation of data from neighboring countries, which
may not accurately reflect the incidence in Laos. There are
important biases in the data from this study, including the fact
that it did not homogenously cover the whole of the country,
that the diagnosis was centralized in the capital with shipment
of blood cultures from five provincial hospital sites, including
one that was specifically sampled to investigate a typhoid
outbreak. Majority of blood cultures (99%) were from inpa-
tients, and hence, estimates will be heavily dependent on
patient health-seeking behavior, access to provincial and
central hospitals, and out-of-pocket cost of patient services,
and therefore, our estimates are likely to be underestimates.
Some outpatients were included, and the samples from the
Oudomxay outbreak were mainly taken in the community.
Access to healthcare centers and laboratories is difficult in
many areas of Laos, particularly in isolated rural areas, which
reduces the number of blood cultures taken and, therefore,
currently makes accurate typhoid surveillance impossible.
There is also very limited laboratory capacity in provincial
hospitals, with only Mahosot Hospital providing an accessi-
ble, free blood culture service in the country. Although typhoid
is a notifiable disease in Laos with the case definition mainly
based on clinical diagnosis and not on culture-positive sam-
ples, without decentralized typhoid surveillance, accurate
understanding of the epidemiology of typhoid in Laos will be
imperfect. There is anecdotal evidence that the frequency of
oral fluoroquinolone use in Laoshas increased in communities
and hospitals over the last 18 years. Hence, if patients with
early symptoms of typhoid are being treated with such effi-
cacious antityphoidal antibiotics at pharmacies and clinics,
manypatientswith typhoidwill not be admitted to hospital.We
FIGURE 4. Total number of inpatients recorded with Salmonella enterica serovar Typhi bloodstream infection per 100,000 people per province
from 2000 to 2018. This figure appears in color at www.ajtmh.org.
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were unable to access data on fluoroquinolone consumption
in Laos through time or the incidence of typhoid-associated
complications, such as intestinal perforation. Nonetheless,
our data are the only substantial body of data about
laboratory-confirmed typhoid within Laos and, despite the
shortcomings, enable some conclusions to be drawn about
the national picture.
There has been a progressive drop in the annual number of
typhoidpatients detectedsince2010,withS. Typhi going from
being the most common organism in blood cultures in the
early 2000s to being recently replaced by Escherichia coli (E.
coli) (unpublished data,Mahosot Hospital). The reason for this
decrease in in-hospital incidence is unclear. Although typhoid
immunization is not part of the routine vaccination program in
Laos, one potential explanation is that people increasingly
have access to saferwater sources. From the Lao census data
collected in 2005 and 2015, there has been a significant
change in the sources of drinking water for many people in
Laos, with people in Vientiane Capital and Vientiane Province
changing from using unprotected well and borehole water in
2005 to predominantly getting their water frombottles in 2015.
Nevertheless, there is still a high percentage of the Lao
population at risk of exposure to contaminated water sources
both in rural and urban settings. One million people (16.7%)
still do not have access to basic water supply, and open def-
ecation remains common, with almost 24% of the population
defecating in the open, with the proportion being higher
among rural than urban populations (32.6% compared with
4.3%).21,22 However, what effect these changes in sources of
drinking water have had on typhoid transmission in Laos has
not been properly studied.
The incidence of the disease appears to be highest in the
rural north of the country, such as in LuangNamtha, bordering
China, where fever surveillance studies have been undertaken
since 2008.18 Although the incidence of typhoid in China is
reported to be low, higher incidences are reported from the
southern provinces that border Laos and Vietnam.23 The one
site in southern Laos, at Salavan Provincial Hospital, had a
comparatively low typhoid inpatient incidence. This province
borders neighboring provinces in Vietnam and Thailand,
where low typhoid incidence has also been reported.3,4 In
Vietnam, most patients present in the Mekong Delta area in
the far south, and in Thailand, most cases are seen in the
northwest.3,4,24
FIGURE 5. Numberof inpatients recordedwithSalmonella entericaserovar Typhi bloodstream infectionper 10,000peopleper district. Zoomed-in
boxes represent Luang Namtha Province and Vientiane Capital and Vientiane Province. This figure appears in color at www.ajtmh.org.
TABLE 2
Antibiotic susceptibility pattern for Salmonella enterica serovar Typhi isolates tested against seven antibiotics (n = total number of isolates tested
against the particular antibiotic) over the 18 years
Antibiotic tested
Ampicillin
(n = 893)
Azithromycin
(n = 740)
Chloramphenicol
(n = 865)
Ceftriaxone
(n = 815)
Ciprofloxacin
(n = 758)
Nalidixic acid
(n = 819)
Co-trimoxazole
(n = 885)
MDRS I R S I R S I R S I R S I R S I R S I R
Number of isolates 818 4 71 739 0 1 788 7 70 739 65 11 723 33 2 798 9 12 814 4 67 59
S = susceptible; I= intermediate; R= resistant; MDR= multi-drug resistant.
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The highest number of typhoid cases in Vientiane capital
came from a rural district (Sangthong), which is the furthest
district from the city center. The high number ofS. Typhi cases
in rural populations has also been seen in other studies in the
region, with the highest burden of typhoid fever in infants seen
in rural communities in Cambodia.25 With the difficulties of
access to immunization in rural Laos, improving penetration of
vaccines into the hinterland will be vital for S. Typhi control.
Given the continuing widespread endemicity of typhoid in
Laos, we agree with United Kingdom recommendations that
most travelers to Laos should be offered typhoid vaccine,
especially because many of these are likely to be more ad-
venturous than most travelers to other countries.16
Although a high proportion of antimicrobial resistance have
been reported in neighboring countries, MDR S. Typhi fre-
quency has been very low in Laos over the last 18 years and
also appears to have recently declined in the region. Although
a high frequency of MDR S. Typhi in children was reported
from Siem Reap, Cambodia, all haplotype H58 and of pre-
dominantly ciprofloxacin intermediate susceptibility,26 an-
other study from Phnom Penh reported a decline in MDR
cases over a 7-year period.27 This decline in MDR frequency
has also been seen in Vietnam since the first-line treatment
shifted from ampicillin, chloramphenicol, and co-trimoxazole
to cephalosporins and quinolones. Salmonella enterica
serovar Typhi antibiotic resistance in Thailand also remains
uncommon.3,4 Of the 59 Lao MDR isolates, the majority of
them (93.2%) were isolated between 2000 and 2004 with only
four isolates cultured since 2004; the majority came from a
single, probably clonal, outbreak in Oudomxay Province. The
majority (96%) of ceftriaxone intermediate and resistant iso-
lates were also obtained between 2000 and 2004. What led to
this dramatic fall in the prevalence of MDR and reduced cef-
triaxone susceptibility after 2004 is unknown. Analysis of a
subset of 183 Lao S. Typhi isolates identified 10 circulating
genotypes.28 Most MDR isolates were from the widely spread
genotype 4.3.1, with two MDR isolates of genotype 3.2.1.
Genotype 3.2.1 appears to be of Asian origin, and MDR iso-
lates within this genotype have been found in Thailand and
Vietnam with antimicrobial resistant (AMR) genes carried on
plasmids of the IncHI1 plasmid sequence type 2.29,30
The reason for this comparative rarity of MDR and reduced
fluoroquinolone and ceftriaxone susceptibility in Laos, despite
the widespread movement of people and widespread and
uncontrolled antibiotic use,31,32 is unclear. Without objective
data on temporal and spatial variation in key antibiotic use in
FIGURE 6. PercentageofSalmonella enterica serovar Typhi (S.Typhi) isolates that are ciprofloxacin andnalidixic acid intermediate or resistant per
year.
FIGURE 7. Percentage of Salmonella enterica serovar Typhi (S. Typhi) isolates which were resistant to ampicillin, chloramphenicol, and co-
trimoxazole multidrug-resistant (MDR) per year.
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Laos, it is hard to judge the relative importance or otherwise of
inappropriate antibiotic use as AMR drivers.
The clinical trial of the treatment of uncomplicated typhoid
conducted at Mahosot Hospital in 2001–2003 demonstrated
that 3 days of ofloxacin was more efficacious than 14 days of
chloramphenicol.13 Although there have been no subsequent
clinical trials, the current clinical evidence and the rarity of
fluoroquinolone resistance support the continued use of
3 days of ofloxacin as the first-line treatment for suspected
typhoid in Laos.
Apart from the outbreak years of 2002 and 2004,whenmost
caseswere seen inMarch, there is generally a peak in cases in
May and June at the end of the dry season followed by re-
duction of cases in the mid-wet season. This pattern was also
described in Cambodia, with most patients presenting in the
hot dry months of March toMay.27 Other studies in Asia, such
as in neighboring Thailand, have shown a more seasonal
pattern following wet seasons and flooding.3,33 The factors
driving this earlier occurrence of cases in Laos could include
limited water sources toward the end of the dry season, with
people having to look for other sources.
In conclusion, this is the largest epidemiological report on
typhoid in Laos. To informdecisions about vaccine introduction,
more typhoid surveillance data and cost-effectiveness analy-
sis are needed. As the use of fluoroquinolones to treat typhoid is
a national policy, and they can be accessed in central, district,
and provincial hospitals as well as pharmacies and private
clinics, continued surveillance of S. Typhi susceptibility to these
agents is critical. Greater understanding of the drivers of fluo-
roquinolone typhoid resistance could inform interventions in
Laos to reduce the risk of a worsening situation. Although mul-
tidrug resistance and fluoroquinolone resistance are not cur-
rently major public health problems, continuous surveillance
and antibiotic stewardship are necessary to prevent a rise in
numbers.
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